StrykerLTS:0R2S +1.17%89 Interest Coverage is 6.32 as of Mar. 2026, which is 42% below its 10-year median of 10.81. GuruFocus rates LTS:0R2S with a GF Score™ of 89/100 and a GF Value™ of $415.62 (Modestly Undervalued). The stock has 1 warning sign investors should review. Among 466 Medical Devices & Instruments companies, Stryker ranks better than 62.23% on this metric.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. Stryker's
Operating Income
for the
three
months ended in Mar. 2026 was $936 Mil. Stryker's Interest Expense for the
three
months ended in Mar. 2026 was $-148 Mil.
Stryker's interest coverage for the quarter that ended in Mar. 2026 was 6.32.
The higher the ratio, the stronger the company's financial strength is.
The historical rank and industry rank for Stryker's Interest Coverage or its related term are showing as below:
LTS:0R2S'
s Interest Coverage Range Over the Past 10 Years
Min: 8.33 Med: 10.81 Max: 34.61
Current: 34.61
LTS:0R2S's Interest Coverage is ranked better than 62.23% of 466
companies
in the Medical Devices & Instruments industry
Industry Median: 15.875
vs LTS:0R2S: 34.61
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
Stryker Interest Coverage Related Terms
Stryker Interest Coverage Historical Data
* Premium members only.
The historical data trend for Stryker's Interest Coverage can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
LTS:0R2S vs MDT, ABT, BSX: Interest Coverage Comparison
For the Medical Devices subindustry, Stryker's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Stryker Interest Coverage vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Stryker's Interest Coverage distribution charts can be found below:
* The bar in red indicates where Stryker's Interest Coverage falls into.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Stryker (LTS:0R2S) has a Interest Coverage of 6.32 as of Mar. 2026. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Stryker and its competitors. This is 42% below median its historical median of 10.81. Over the past decade, Stryker's Interest Coverage has ranged from 8.33 to 34.61. According to the industry distribution chart, Stryker ranks #176 out of 466 companies in the Medical Devices & Instruments industry, placing it in the top 37.8%.
Is Stryker's Interest Coverage too high?
Stryker's current Interest Coverage of 6.32 is 42% below median its 10-year median of 10.81. Over the past 10 years, this metric has ranged from a low of 8.33 to a high of 34.61. The Medical Devices & Instruments industry median Interest Coverage is 15.88. Stryker's value of 6.32 is 60.2% below this industry median. Based on the distribution chart, Stryker ranks #176 out of 466 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Stryker has a GF Score™ of 89/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Stryker's Interest Coverage compare to MDT and ABT?
According to the Medical Devices & Instruments industry distribution chart, Stryker ranks #176 out of 466 companies for Interest Coverage. This puts Stryker in the upper half of its industry. The industry median Interest Coverage is 15.88. Stryker's value of 6.32 is 60.2% below this benchmark. Historically, Stryker's own Interest Coverage has ranged from 8.33 to 34.61 over the past decade. While the company's 10-year median is 10.81 vs. the industry median of 15.88, Stryker has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Medical Devices & Instruments company?
The median Interest Coverage among Medical Devices & Instruments companies is 15.88, based on 466 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Stryker's current Interest Coverage of 6.32 is 60.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Stryker and its competitors. For the Medical Devices & Instruments industry, the median Interest Coverage is 15.88 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Stryker's current Interest Coverage is 6.32, which is 42% below median its own 10-year median of 10.81. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Stryker stock overvalued right now?
Based on GuruFocus' analysis, Stryker (LTS:0R2S) is currently considered Modestly Undervalued. The stock's GF Value™ is $415.62, compared to a current price of $334.21 — trading 19.6% below its estimated fair value. The current Interest Coverage is 6.32, which is 42% below median its 10-year median of 10.81 and 60.2% below the Medical Devices & Instruments industry median of 15.88. Stryker's overall GF Score™ is 89/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Stryker (LTS:0R2S), the current Interest Coverage is 6.32 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Stryker (LTS:0R2S) Overvalued in 2026?
Based on GuruFocus' analysis, Stryker stock appears to be undervalued.
The current stock price of $334.21 is trading 19.6% below its estimated GF Value™ of $415.62.
GuruFocus considers Stryker to be Modestly Undervalued.
Key valuation signals for LTS:0R2S:
Interest Coverage: 6.32 (42% below median its 10-year median of 10.81)
GF Value™: $415.62 vs. price of $334.21 (19.6% below fair value)
Industry Position: 60.2% below the Medical Devices & Instruments median (#176 of 466)
No single metric tells the full story. See the LTS:0R2S stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, extremities, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and orthopedic robotics. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Roughly one-fourth of Stryker's total revenue currently comes from outside the United States.
89GF Score
Get the complete analysis for LTS:0R2S
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LTS:0R2S has been successfully added to your 
